Advertisement

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Amit Sanyal, MD: A Clinician’s Perspective

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

The Interventional Pharmacoeconomic Toolbox Panel Discussion

David A. Hyman, MD, JD, on Inclusive Shared Savings

Advertisement

Advertisement

Jan

22

Today In Oncology

Limited or No State Regulation of STLD Health Plans Linked to Decreases in Timely Cancer Treatment Initiation

FDA Releases Draft Guidance for Use of MRD and CR as Primary Endpoints in Multiple Myeloma Trials

Breast Cancer Recurrence Risk Determined by Deep Learning Model Trained on Histopathologic Slides

Regulatory Agencies Establish Principles of Good AI Use in Drug Development

Addition of Durvalumab to BCG After TURBT for BCG-Naive, High-Risk NMIBC

Advertisement

© 2026 HSP News Service, L.L.C.